PortfolioMatthias Schwab
Personendaten
Akademischer Titel:
PD Dr.
Name:
Matthias Schwab
Einrichtungen:
Medizinische Fakultät
Universität Tübingen
Exzellenzcluster: Individualisierung von Tumortherapien durch molekulare Bildgebung und funktionelle Identifizierung therapeutischer Zielstrukturen (iFIT)
Zentren oder interfakultäre wissenschaftliche Einrichtungen
Graduiertenkolleg: Nicht-kanonische G-Protein-abhängige Signalwege
Graduiertenkollegs
Kontaktdaten
Lebenslauf
Academic Education and Degrees
| 1983 - 1990 | Study of medicine, Friedrich-Alexander University Erlangen Nürnberg, Germany |
| 1991 | M.D., Institute of Toxicology & Pharmacology, University Erlangen, Germany |
| 1996 / 2000 | Board Certification: Pediatrics and Adolescent Medicine / Clinical Pharmacology |
| 2003 | Habilitation, Clinical and Pediatric Pharmacology, University Tübingen, Germany |
Scientific Career and Positions
| since 2015 | Coopted Professor at the Faculty of Mathematics and Natural Sciences, Department of Pharmacy and Biochemistry, Eberhard Karls University Tübingen, Germany |
| since 2007 | Professor & Chair of Clin. Pharmacology, University Tübingen and Director of the Dr Margarete Fischer-Bosch Institute of Clin. Pharmacology, Stuttgart, Germany |
| 2001 - 2005 | Senior physician & Head of the Research of Clinical Trial Unit and Drug Information, Dr Margarete Fischer-Bosch Institute of Clin. Pharmacology, Stuttgart, Germany |
| 2005 - 2006 | Visiting Professor, St. Jude Children’s Research Hospital, Department of Pharmaceutical Sciences, Memphis, Tennessee, USA |
| 1995 - 2001 | Fellow in clinical pharmacology, Dr. Margarete Fischer-Bosch Institute of Clin. Pharmacology, Stuttgart, Germany |
| 1990 - 1995 | Civilian service and fellow in pediatrics / Senior house officer, University Hospital of Children and Adolescents, University Erlangen-Nürnberg, Germany |
Awards
| 2015 + 2016/17 | Thomson Reuters Highly Cited Researchers, rubric “Pharmacology and Toxicology” |
| 2016 | Robert-Pfleger Research Award |
| 2015 | “Staufermedaille in Gold” by the Prime Minister of Baden Württemberg |
| 2014 | Member of the German National Academy of Sciences ‘Leopoldina’ |
| 2013 | Most cited German pharmacologist in Europe (LabTimes, 2013) |
| 2012 | Full Member of the Academy of Science and Literature, Mainz, Germany |
| 2009 | Most cited pharmacologist in German-speaking countries (Laborjournal, 2009) |
| 2005 | Galenus von Pergamon Award |
| 2004 | Friedrich Hartmut Dost Award |
| 1983 - 1990 | Scholarship according to the "Bayerischen Begabtenförderungsgesetz" |
Memberships: Editorial Boards and Societies
| 2015 | President of the German Society of Exp. and Clin. Pharmacology and Toxicology |
| since 2014 | Member and Chair, Commission for Medical Research, Academy of Science and Literature Mainz, Germany |
| since 2013 | Chair, German Society of Clinical Pharmacology (DGKliPha) |
| since 2010 | Executive Board member and vice chair (2014-2018) of the Drug Metabolism and Transporter Section, Intern. Union of Basic and Clinical Pharmacology (IUPHAR) |
| since 2010 | Executive Committee, European Association of Clin. Pharmacology and Therapy |
| since 2008 | Section Editor PGx & Personalized Medicine of Genome Medicine |
| since 2007 | Editor-in-Chief of Pharmacogenetics & Genomics |
| since 2004 | Full Member & Vice Chair, Expert Group "Drugs for Children & Adolescents", BfArM |
Patente
04.04.2019
Lusine Danielyan, Christoph Gleiter, Matthias Schwab
Gayane Buniatian, Ralf Weiskirchen, Thomas Weiss
27.08.2012
Lusine Danielyan, Christoph Gleiter, Barbara Proksch, Matthias Schwab
Projekte
2020 - 2022
Oliver Kohlbacher
Bundesministerium für Bildung und Forschung (BMBF)
2019 - 2025
Lars Zender, Bernd Pichler, Hans-Georg Rammensee
Deutsche Forschungsgemeinschaft e.V. (DFG)